Search - tctmd.com

Displaying 121 - 140 of 213

Sort: Relevancy | Date

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

L.A. McKeown

August 24, 2016

News Daily News

Mejor Supervivencia y Ausencia de ‘Tendencia de Riesgo’ para TAVR vs Cirugía en Pacientes de Menor Riesgo

L.A. McKeown

August 24, 2016

News Daily News

简单风险评分系统预测 TAVR 后死亡率

Michael O'Riordan

July 25, 2016

News Daily News

Un Sistema Simple de Puntuación del Riesgo Predice la Mortalidad Post-TAVR

Michael O'Riordan

July 25, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Daily News

小组认为经颈动脉 TAVR 是可行的，且可取代经股动脉的其他替代方案

Shelley Wood

March 07, 2016

News Daily News

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Shelley Wood

March 07, 2016

News Daily News

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

Shelley Wood

March 07, 2016

News Industry News

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

February 21, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Daily News

报告首次概述了商业化 TAVR 的经验

Todd Neale

November 30, 2015

News Daily News

Un Informe Ofrece una Visión de la Experiencia Comercial Inicial de la TAVR

Todd Neale

November 30, 2015

News Daily News

Report Provides Snapshot of Initial Commercial TAVR Experience

Todd Neale

November 30, 2015

Presentation TCT 2015

TCT 106: Cardiovascular Magnetic Resonance for the Evaluation of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Insights on Clinical Outcomes

Presenter: Michael J. Reardon, Torsten P. Vahl, Henrique Ribeiro

October 13, 2015

Presentation TCT 2015

TCT 105: Transcatheter Aortic Valve Implantation Using a New Second-Generation TAVI System J-Valve for High-Risk Patients With Pure Aortic Regurgitation

Presenter: Michael J. Reardon, Torsten P. Vahl, Yingqiang Guo

October 13, 2015

Presentation TCT 2015

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

Presenter: Michael J. Reardon, Torsten P. Vahl, Sung-Han Yoon

October 13, 2015

Presentation TCT 2015

TCT 103: National Variation in Post-TAVR Antithrombotic Therapy Utilization and Associated Outcomes Insights From the STS/ACC TVT Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Matthew Sherwood

October 13, 2015

Presentation TCT 2015

TCT 102: SAPIEN 3 Implantation in Failed Surgical Aortic Bioprostheses Matched Comparison and Insights From the Valve-in-Valve International Data (VIVID) Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Moritz Seiffert

October 13, 2015

Presentation TCT 2015

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Tobias Schmidt

October 13, 2015

Presentation TCT 2015

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Presenter: Michael J. Reardon, Torsten P. Vahl, Daniel O'Hair

October 13, 2015

Advertisement

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

Mejor Supervivencia y Ausencia de ‘Tendencia de Riesgo’ para TAVR vs Cirugía en Pacientes de Menor Riesgo

简单风险评分系统预测 TAVR 后死亡率

Un Sistema Simple de Puntuación del Riesgo Predice la Mortalidad Post-TAVR

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

小组认为经颈动脉 TAVR 是可行的，且可取代经股动脉的其他替代方案

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

报告首次概述了商业化 TAVR 的经验

Un Informe Ofrece una Visión de la Experiencia Comercial Inicial de la TAVR

Report Provides Snapshot of Initial Commercial TAVR Experience

TCT 106: Cardiovascular Magnetic Resonance for the Evaluation of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Insights on Clinical Outcomes

TCT 105: Transcatheter Aortic Valve Implantation Using a New Second-Generation TAVI System J-Valve for High-Risk Patients With Pure Aortic Regurgitation

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

TCT 103: National Variation in Post-TAVR Antithrombotic Therapy Utilization and Associated Outcomes Insights From the STS/ACC TVT Registry

TCT 102: SAPIEN 3 Implantation in Failed Surgical Aortic Bioprostheses Matched Comparison and Insights From the Valve-in-Valve International Data (VIVID) Registry

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content